Zealand Pharma A/S (LON: 0NZU)
London
· Delayed Price · Currency is GBP · Price in DKK
712.00
+0.75 (0.11%)
At close: Jan 21, 2025
Zealand Pharma Revenue
Zealand Pharma had revenue of 4.42M DKK in the quarter ending September 30, 2024, a decrease of -98.51%. This brings the company's revenue in the last twelve months to 76.87M, down -77.62% year-over-year. In the year 2023, Zealand Pharma had annual revenue of 342.79M with 229.65% growth.
Revenue (ttm)
76.87M DKK
Revenue Growth
-77.62%
P/S Ratio
n/a
Revenue / Employee
303.83K DKK
Employees
253
Market Cap
5.91B GBP
Revenue Chart
* This company reports financials in DKK.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 342.79M | 238.80M | 229.65% |
Dec 31, 2022 | 103.99M | -4.56M | -4.20% |
Dec 31, 2021 | 108.55M | -83.46M | -43.47% |
Dec 31, 2020 | 192.00M | 150.67M | 364.52% |
Dec 31, 2019 | 41.33M | 3.36M | 8.84% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 38.20B |
Shell | 221.41B |
HSBC Holdings | 43.25B |
Unilever | 51.12B |
Rio Tinto Group | 42.87B |
RELX PLC | 9.30B |
BP p.l.c. | 144.69B |
British American Tobacco p.l.c. | 26.18B |